LIAONING CHENGDA BIOTECHNOLOGY CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.21 CNY | -0.08% |
|
-7.81% | -25.53% |
| 05-20 | Wall Street Cues, Central Bank Outlooks Lift Asian Stock Markets | MT |
| 04-29 | Liaoning Chengda Biotechnology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.38B | - | - | - | - | ||
| 94.22B | ||||||
| 37.76B | ||||||
| 32.5B | ||||||
| 27.75B | ||||||
| 16.13B |
